ENVERIC BIOSCIENCES, INC. (ENVB)
Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model
Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model
Estrella Immunopharma to Participate in the D. Boral Capital Global Conference
NImmune Biopharma Announces Presentations at Digestive Disease Week 2026 Supporting a Differentiated Profile and Superior Efficacy of Oral, Once-Daily NIM-1324 for IBD
red violet to Present at the 26th Annual B. Riley Securities Investor Conference
Clene to Present at Upcoming May Conferences
Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results
Bay Area Luxury Home Prices Have Jumped 13% Since Launch of ChatGPT
Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026
SABINE ROYALTY TRUST ANNOUNCES MONTHLY CASH DISTRIBUTION FOR MAY 2026
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)